The order to place cannabis in the same category as Tylenol with codeine would mark the most significant change in US drug policy since 1971.

Donald Trump spoke about the cannabis industry in the Oval Office on Monday

Reclassification to a Schedule III drug and possible Medicare coverage for pot could unlock new investment from pharmaceutical companies.

The move to Schedule III marks the greatest change to U.S. drug laws since 1970 and represents a new future for the $32 billion cannabis industry.

The order to place cannabis in the same category as Tylenol with codeine would mark the most significant change in US drug policy since 1971.

President Donald Trump signed an executive order Thursday reclassifying marijuana as a Schedule III substance with looser restrictions.

Trump signed an executive order reclassifying marijuana as a less dangerous drug. The change could help the industry without legalizing the drug.

The switch would move marijuana away from its current classification as a Schedule I drug, alongside heroin and LSD. Cannabis would instead be a Schedule III substance, like…

Change will loosen limits on research and certain regulations but stops short of making marijuana legal

President Donald Trump on Thursday ordered the federal government to hasten marijuana reclassification to enable research into its medicinal uses.

The order calls on the US attorney general to expedite federal reclassification, creating fewer barriers for studies.